Key Focus: China to Strengthen Standardized Cancer Diagnosis and Treatment, Recently Establishes Five Major Cancer Quality Control Centers

Posted by

6 2 月, 2026

On 6 2 月, 2026

Introduction:

Recently,the National Conference on Standardized Cancer Diagnosis and Treatment and the Summit Forum on Multidisciplinary Diagnosis and Treatment and Translational Research of Tumors were successfully held.At the conference, the National Cancer Center and the National Cancer Quality Control Center established five new tumor quality control committees for lung cancer, liver cancer, esophageal cancer, cervical cancer, and ovarian cancer. Thus, including breast cancer and colorectal cancer, the number of national-level tumor quality control committees will reach seven, marking thatChina will comprehensively deepen and strengthen the quality control work for single-disease tumors, standardizingthe diagnosis and treatment activities of medical institutions at all levels, which has positive and constructive significance for improving the level of cancer diagnosis and treatment in China.

　 Currently,the incidence of cancer in China is continuously rising, and cancer has become the primary cause threatening the life and health of the Chinese people. With the development of the medical field, significant progress has been made in the diagnosis and treatment of tumors in many aspects such as innovative technologies and translational research, especially in the era of precision medicine and personalized treatment, where many cancer patients have greatly benefited from targeted therapy.

“Diagnosis” Comes First

Precise diagnosis is the prerequisite and foundation for precise treatment; without correct diagnosis, treatment cannot be discussed. Therefore, actively promotingTumorthe standardization of diagnosis and vigorously developing multidisciplinary diagnosis and treatment models will further improve the diagnostic quality of medical institutions at all levels, directly promoting the enhancement of tumor treatment levels, ultimately benefiting the vast number of tumor patients.

pathological diagnosis is recognized as the “gold standard” for tumor diagnosis, it is the final diagnosis that cannot be replaced by any other means at present, and it is also the most reliable basis for guiding clinical treatment and prognosis assessment. Pathological diagnosis formulates corresponding personalized plans by analyzing different pathological types of tumors, gene mutation status, different stages, and the patient’s physical condition, thereby improving clinical treatment outcomes. This will also become an important development direction for future tumor diagnosis and treatment,determining the success or failure of precise treatment.。

High Requirements for Diagnostic Quality

The establishment of these five national-level tumor quality control centersmeans that the era of personalized medicine places higher demands on the standardization of pathological diagnosis work and the level of diagnostic quality.Pathologists,industry associationsas well as upstream and downstream enterprises involved in all aspects of pathological diagnosis, how to activelyexploreandjointly buildmore scientific, intelligent,Standardsand standardized new diagnostic models to meet the increasingly high-quality and efficient clinical demands is particularly important.

Based on Pathology, Walking with Responsibility

Since its establishment in 1993, Maxin has envisioned a beautiful blueprint of bringing immunohistochemistry technology into every pathology department, committed to promoting the quality control and standardization process of IHC.

We strictly control product quality, have participated multiple times in quality control activities such as NordiQc and CCPI, achieving excellent results; we adhere to scientific research and innovation, independently developedDomestically,the first fully automatic pathological staining system, breaking foreign monopolies, making “domestic substitution” no longer just a slogan.with the development of the pathology field, immunohistochemistry technology plays an increasingly important role in the daily diagnosis of pathologists, andevery automated instrument and every antibody we produce will directly relate to pathological diagnosis results，and relate to the life and health of tumor patients.This is not only the supreme honor but also an inescapable responsibility.

The national strengthening of standardized cancer diagnosis and treatment is both a challenge and an opportunity for Maxin. We will grasp the pulse of the times, continue to delve deeply into pathology, wholeheartedly serve pathology workers, and play a greater role in areas such as tumor diagnosis, companion diagnostics, and molecular pathology, thereby benefiting more tumor patients.

发表回复 取消回复

发表回复取消回复